Inhibition of FAK in pancreatic cancer murine models reduces collagen deposition, decreases anti-inflammatory immune cells, increases CD8+ T cells, and improves the efficacy of TIL-based and checkpoint inhibitor therapy (118). The gene discussed is PTK2; the disease is pancreatic neoplasm.